Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
5.15
-0.40 (-7.21%)
At close: Dec 12, 2025
24.70% (1Y)
| Market Cap | 17.41B |
| Revenue (ttm) | 5.88B |
| Net Income (ttm) | 459.25M |
| Shares Out | n/a |
| EPS (ttm) | 0.31 |
| PE Ratio | 37.90 |
| Forward PE | n/a |
| Dividend | 0.27 (5.03%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 4,198,500 |
| Average Volume | 897,400 |
| Open | 5.47 |
| Previous Close | 5.55 |
| Day's Range | 5.15 - 5.53 |
| 52-Week Range | 3.56 - 7.26 |
| Beta | 0.43 |
| RSI | 58.84 |
| Earnings Date | Mar 26, 2026 |